Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chart: FDA's ANDA Approvals

Executive Summary

FDA's ANDA Approvals



FDA's ANDA Approvals

Applicant

Active Ingredients

Number

Date Approved

Perrigo

Cetirizine HCl syrup, 1 mg/mL (Rx only)

78-398

6/17/2008

OHM

Metoprolol tartrate USP, 25 mg, 50 mg and 100 mg tabs.

78-459

6/17/2008

Hospira

Hydromorphone HCl USP, 10 mg/mL; packaged in 10 mg/1 mL, 50 mg/5 mL and 500 mg/50 mL single-use vials inj.

78-591

6/17/2008

Teva

Ramipril, 1.25 mg, 2.5 mg, 5 mg and 10 mg caps.

77-470

6/18/2008

Ranbaxy

Cetirizine HCl syrup, 1 mg/mL (Rx only)

77-472

6/18/2008

Actavis

Ramipril, 1.25 mg, 2.5 mg, 5 mg and 10 mg caps.

77-513

6/18/2008

Sandoz

Ramipril, 1.25 mg, 2.5 mg, 5 mg and 10 mg caps.

77-514

6/18/2008

Roxane

Ramipril, 1.25 mg, 2.5 mg, 5 mg and 10 mg caps.

77-900

6/18/2008

Dr. Reddy's

Ramipril, 1.25 mg, 2.5 mg, 5 mg and 10 mg caps.

78-191

6/18/2008

Apotex

Cetirizine HCl syrup, 1 mg/mL (Rx only)

78-412

6/18/2008

Glenmark

Trandolapril, 1 mg, 2 mg and 4 mg tabs.

78-508

6/18/2008

Invagen

Ramipril, 1.25 mg, 2.5 mg, 5 mg and 10 mg caps.

78-745

6/18/2008

Tentative Approvals

Roxane

Buprenorphine HCl sublingual, 2 mg (base) and 8 mg (base) tabs.

78-633

6/18/2008

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049805

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel